Wikipedia
CapeRay Medical (Pty) Ltd is a privately held company based in Cape Town, South Africa, that develops, manufactures and supplies medical imaging equipment for the diagnosis of breast cancer. The company was originally formed as African Medical Imaging (AMI) in 1999 as a joint venture between De Beers and the University of Cape Town.
Funding for the company came first from the Innovation Fund of South Africa which is now part of the Technology Innovation Agency, followed by a grant from the National Institutes of Health in the USA, and finally an investment by the venture capital unit of the Industrial Development Corporation of South Africa. Kit Vaughan is founder and CEO, having facilitated the formation of CapeRay as a spin out company.
CapeRay has developed a digital mammography system known as the PantoScanner which brings a dual modality approach to breast cancer screening, combining automated breast ultrasound and low dose digital x-rays to provide complementary information on the composition of breast tissue. The PantoScanner, which also incorporates digital tomosynthesis, combines the attributes of each modality to improve the sensitivity and specificity for detecting breast cancer.